Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jul 1, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Biomarkers in systemic sclerosis.

J P Doran¹, D J Veale

¹Department of Rheumatology, Bone and Joint Unit, Dublin Academic Healthcare, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.

Rheumatology (Oxford, England)

|September 17, 2008

Summary

Finding reliable biomarkers for systemic sclerosis (SSc), a rare connective tissue disease (CTD), is challenging due to its variable presentation. A collaborative international approach is highlighted as key to discovering diagnostic and prognostic markers.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Biological DMARD survival in rheumatoid arthritis patients in clinical practice: a METEOR registry data analysis.

Rheumatology international·2025

Same author

Rheumatoid arthritis synovial microenvironment induces metabolic and functional adaptations in dendritic cells.

Clinical and experimental immunology·2020

Same author

Enhanced angiogenic function in response to fibroblasts from psoriatic arthritis synovium compared to rheumatoid arthritis.

Arthritis research & therapy·2019

Same author

Increased T Cell Plasticity With Dysregulation of Follicular Helper T, Peripheral Helper T, and Treg Cell Responses in Children With Juvenile Idiopathic Arthritis and Down Syndrome-Associated Arthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2019

Same author

Ankylosing Spondylitis Response to TNF Inhibition Is Gender Specific: A 6-Year Cohort Study

Irish medical journal·2018

Same author

Is current smoking status and its relationship to anti-cyclic citrullinated peptide antibodies a predictor of worse response to biological therapies in rheumatoid arthritis patients?

Scandinavian journal of rheumatology·2018

Area of Science:

Rheumatology
Immunology
Genetics

Background:

Systemic sclerosis (SSc) is a rare connective tissue disease (CTD) characterized by critical organ fibrosis and highly variable clinical presentations.
The heterogeneity of SSc complicates classification, diagnosis, prognosis, and therapeutic response assessment.
Existing biomarker research is limited by small cohorts and challenges in defining clear clinical characteristics and outcomes.

Purpose of the Study:

To review the current knowledge on biomarkers for SSc.
To highlight the potential of international collaborative efforts in biomarker discovery for SSc.

Main Methods:

Review of existing literature on SSc biomarkers.
Discussion of challenges in SSc research, including classification and cohort size.

Related Experiment Videos

Last Updated: Jul 1, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Emphasis on the potential of large-scale, multicenter, international collaborations.

Main Results:

Biomarker discovery in SSc has been historically challenging due to disease heterogeneity and rarity.
Current biomarkers are often identified in small cohorts with limited clinical definition.
A significant potential exists for future biomarker discovery through international collaboration.

Conclusions:

Addressing the challenges in SSc classification and cohort definition is crucial for biomarker development.
Large-scale, multicenter, international collaborative approaches offer the most promising avenue for identifying robust SSc biomarkers.
Future research should focus on these collaborative models to advance diagnostic, prognostic, and therapeutic strategies for SSc.